Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.
Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe.
复制标题
新型和选择性骨形态发生蛋白受体(BMP)抑制剂的合成和结构活性关系从吡唑洛斯[1.5-A]吡胺胺的嘧啶支架衍生而来:ML347的发现ML347作为ALK2对ALK2对ALK3对ALK3的选择性MLPCN探针。
DOI:
10.1016/j.bmcl.2013.03.113
复制
发表时间:
2013-06-01
影响因子:
2.7
通讯作者:
Hopkins, Corey R.
中科院分区:
文献类型:
--
作者:
Engers, Darren W.;Frist, Audrey Y.;Lindsley, Craig W.;Hong, Charles C.;Hopkins, Corey R.
A structure-activity relationship of the 3- and 6-positions of the pyrazolo[1,5-a]pyrimidine scaffold of the known BMP inhibitors dorsomorphin, 1, LDN193189, 2, and DMH1, 3, led to the identification of a potent and selective compound for ALK2 versus ALK3. The potency contributions of several 3-position substituents were evaluated with subtle structural changes leading to significant changes in potency. From these studies, a novel 5-quinoline molecule was identified and designated an MLPCN probe molecule, ML347, which shows >300-fold selectivity for ALK2 and presents the community with a selective molecular probe for further biological evaluation.
登录
查看更多内容
影响因子:
1.8
作者:
Daniels, R. Nathan;Kim, Kwangho;Lindsley, Craig W.
通讯作者:
Lindsley, Craig W.
影响因子:
6.1
作者:
Shi, SongTing;Hoogaars, Willem M. H.;'t Hoen, Peter A. C.
通讯作者:
't Hoen, Peter A. C.
影响因子:
30.8
作者:
Shore, EM;Xu, MQ;Kaplan, FS
通讯作者:
Kaplan, FS
影响因子:
14.8
作者:
Yui, Paul B.;Hong, Charles C.;Peterson, Randall T.
通讯作者:
Peterson, Randall T.
影响因子:
82.9
作者:
通讯作者:
--